Skip to Main Content
Table I.

Anti-CD4 mAb Treatment Does Not Induce LLO91–99–specific CD8+ Memory T Cell Proliferation in the Absence of Antigen Stimulation




Percent
 LLO91–99-tetramer+
 of CD8+ cells

LLO91–99-tetramer+CD8+
 cells/spleen
Naive  <0.02 <1,000 
+ anti-CD4 mAb  <0.02 <1,000 
L. monocytogenes 0.06 ± 0.01 1,700 ± 100 
+ anti-CD4 mAb 0.07 ± 0.04 2,700 ± 1,600 
Gene gun 0.09 ± 0.04 3,900 ± 2,800 
+ anti-CD4 mAb
 
0.10 ± 0.03
 
3,400 ± 900
 



Percent
 LLO91–99-tetramer+
 of CD8+ cells

LLO91–99-tetramer+CD8+
 cells/spleen
Naive  <0.02 <1,000 
+ anti-CD4 mAb  <0.02 <1,000 
L. monocytogenes 0.06 ± 0.01 1,700 ± 100 
+ anti-CD4 mAb 0.07 ± 0.04 2,700 ± 1,600 
Gene gun 0.09 ± 0.04 3,900 ± 2,800 
+ anti-CD4 mAb
 
0.10 ± 0.03
 
3,400 ± 900
 

Mice were infected with L. monocytogenes or immunized with pChly DNA using the gene gun. After 2 mo, mice were treated with anti-CD4 mAb or were left untreated. Injection of anti-CD4 mAb was repeated after 5 d, and 10 d after the first mAb injection mice were killed, spleen cells were counted, stained with anti-CD8 mAb, anti-CD62L mAb, and LLO91–99-tetramers, and analyzed by flow cytometry. Since in the spleen, a subpopulation of memory CD8+ T cells reacquires CD62L expression, results are given for total CD8+ T cells (CD62Llow and CD62Lhigh). Data represent mean ± SD of three mice per group. The experiment shown is representative for two individual experiments with similar results.

Close Modal

or Create an Account

Close Modal
Close Modal